Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids

Inhibiting clathrin-mediated endocytosis of the leucine-rich G protein-coupled receptor-5 diminishes cell fitness

(2017) Joshua C. Snyder et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Intra-tumor heterogeneity from a cancer stem cell perspective

(2017) Pramudita R. Prasetyanti et al.   Molecular Cancer

A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer

(2017) Felipe de Sousa e Melo et al.   NATURE

Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer

(2017) Maria Chiara Proto et al.   Scientific Reports

Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer

(2016) Hideki Osawa et al.   BRITISH JOURNAL OF CANCER

A user’s guide to cannabinoid therapies in oncology

(2016) V. Maida et al.   Current Oncology

From tumour heterogeneity to advances in precision treatment of colorectal cancer

(2016) Cornelis J. A. Punt et al.   Nature Reviews Clinical Oncology

Cancer stem cells and chemoresistance: The smartest survives the raid

(2016) Jihe Zhao   PHARMACOLOGY & THERAPEUTICS

Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer

(2016) Huai-Xiang Hao et al.   Cancers

Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer

(2015) Lele Song et al.   Clinical Colorectal Cancer

Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner

(2015) Massimo Nabissi et al.   INTERNATIONAL JOURNAL OF CANCER

The consensus molecular subtypes of colorectal cancer

(2015) Justin Guinney et al.   NATURE MEDICINE

Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update

(2015) Naoko Takebe et al.   Nature Reviews Clinical Oncology

Altering cancer transcriptomes using epigenomic inhibitors

(2015) Malaina Gaddis et al.   Epigenetics & Chromatin

Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells

(2015) Elena Ciaglia et al.   Oncotarget

Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells

(2014) S Colak et al.   CELL DEATH AND DIFFERENTIATION

Colorectal Cancer Stem Cells: From the Crypt to the Clinic

(2014) Ann Zeuner et al.   Cell Stem Cell

Cancer stem cells - important players in tumor therapy resistance

(2014) Selcuk Colak et al.   FEBS Journal

Ex vivo culture of the intestinal epithelium: strategies and applications

(2014) Marc Leushacke et al.   GUT

RSPO2–LGR5 signaling has tumour-suppressive activity in colorectal cancer

(2014) Changjie Wu et al.   Nature Communications

Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer

(2013) Hung-Chih Hsu et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Constitutive Internalization of the Leucine-rich G Protein-coupled Receptor-5 (LGR5) to the Trans-Golgi Network

(2013) Joshua C. Snyder et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Wnt/β-Catenin Signaling and Disease

(2012) Hans Clevers et al.   CELL

Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells

(2012) Chiara Laezza et al.   EUROPEAN JOURNAL OF CANCER

Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors

(2012) Bon-Kyoung Koo et al.   NATURE

Molecular Genetics of Colorectal Cancer

(2011) Eric R. Fearon   Annual Review of Pathology-Mechanisms of Disease

Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium

(2011) Toshiro Sato et al.   GASTROENTEROLOGY

Interaction of endocannabinoid system and steroid Hormones in the control of colon cancer cell growth

(2011) Maria C. Proto et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice

(2011) Anna Maria Malfitano et al.   PHARMACOLOGICAL RESEARCH

R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/ -catenin signaling

(2011) K. S. Carmon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

(2010) Louis Vermeulen et al.   NATURE CELL BIOLOGY

Cannabinoids and the gut: New developments and emerging concepts

(2010) Angelo A. Izzo et al.   PHARMACOLOGY & THERAPEUTICS

Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon

(2009) Antonietta Santoro et al.   INTERNATIONAL JOURNAL OF CANCER

β-Catenin hits chromatin: regulation of Wnt target gene activation

(2009) Christian Mosimann et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway

(2008) Sharon DeMorrow et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil

(2008) Sofia B. Gustafsson et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor  -Mediated Ceramide De novo Synthesis in Colon Cancer Cells

(2008) F. Cianchi et al.   CLINICAL CANCER RESEARCH